Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy.

Victor E. Marquez; James A. Kelley; Riad Agbaria; Tisipi Ben-Kasus; Jonathan C. Cheng; Christine B. Yoo; Peter A. Jones

doi:10.1196/annals.1359.037

Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy.

Victor E. Marquez
, James A. Kelley
, Riad Agbaria
, Tisipi Ben-Kasus
, Jonathan C. Cheng
, Christine B. Yoo
, Peter A. Jones

Research output: Contribution to journal › Review article › peer-review

83 Scopus citations

Abstract

1-(Beta-d-ribofuranosyl)-1,2-dihydropyrimidin-2-one (zebularine) corresponds structurally to cytidine minus the exocyclic 4-amino group. The increased electrophilic character of its simple aglycon endows the molecule with unique biologic properties as a potent inhibitor of both cytidine deaminase and DNA cytosine methyltransferase. The latter activity makes zebularine a promising antitumor agent that is hydrolytically stable, preferentially targets cancer cells, and shows activity both in vitro and in experimental animals, even after oral administration.

Original language	English
Pages (from-to)	246-254
Number of pages	9
Journal	Annals of the New York Academy of Sciences
Volume	1058
DOIs	https://doi.org/10.1196/annals.1359.037
State	Published - 1 Jan 2005
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

General Neuroscience
General Biochemistry, Genetics and Molecular Biology
History and Philosophy of Science

Access to Document

10.1196/annals.1359.037

Cite this

@article{eb3ef1d66fdf4c9290245396afdb6690,

title = "Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy.",

abstract = "1-(Beta-d-ribofuranosyl)-1,2-dihydropyrimidin-2-one (zebularine) corresponds structurally to cytidine minus the exocyclic 4-amino group. The increased electrophilic character of its simple aglycon endows the molecule with unique biologic properties as a potent inhibitor of both cytidine deaminase and DNA cytosine methyltransferase. The latter activity makes zebularine a promising antitumor agent that is hydrolytically stable, preferentially targets cancer cells, and shows activity both in vitro and in experimental animals, even after oral administration.",

author = "Marquez, \{Victor E.\} and Kelley, \{James A.\} and Riad Agbaria and Tisipi Ben-Kasus and Cheng, \{Jonathan C.\} and Yoo, \{Christine B.\} and Jones, \{Peter A.\}",

year = "2005",

month = jan,

day = "1",

doi = "10.1196/annals.1359.037",

language = "English",

volume = "1058",

pages = "246--254",

journal = "Annals of the New York Academy of Sciences",

issn = "0077-8923",

publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Zebularine

T2 - a unique molecule for an epigenetically based strategy in cancer chemotherapy.

AU - Marquez, Victor E.

AU - Kelley, James A.

AU - Agbaria, Riad

AU - Ben-Kasus, Tisipi

AU - Cheng, Jonathan C.

AU - Yoo, Christine B.

AU - Jones, Peter A.

PY - 2005/1/1

Y1 - 2005/1/1

N2 - 1-(Beta-d-ribofuranosyl)-1,2-dihydropyrimidin-2-one (zebularine) corresponds structurally to cytidine minus the exocyclic 4-amino group. The increased electrophilic character of its simple aglycon endows the molecule with unique biologic properties as a potent inhibitor of both cytidine deaminase and DNA cytosine methyltransferase. The latter activity makes zebularine a promising antitumor agent that is hydrolytically stable, preferentially targets cancer cells, and shows activity both in vitro and in experimental animals, even after oral administration.

AB - 1-(Beta-d-ribofuranosyl)-1,2-dihydropyrimidin-2-one (zebularine) corresponds structurally to cytidine minus the exocyclic 4-amino group. The increased electrophilic character of its simple aglycon endows the molecule with unique biologic properties as a potent inhibitor of both cytidine deaminase and DNA cytosine methyltransferase. The latter activity makes zebularine a promising antitumor agent that is hydrolytically stable, preferentially targets cancer cells, and shows activity both in vitro and in experimental animals, even after oral administration.

UR - https://www.scopus.com/pages/publications/33745312816

U2 - 10.1196/annals.1359.037

DO - 10.1196/annals.1359.037

M3 - Review article

C2 - 16394141

AN - SCOPUS:33745312816

SN - 0077-8923

VL - 1058

SP - 246

EP - 254

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

ER -

Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy.

Abstract

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this